ONLY GOOD BEHAVIOR FOUND HERE

ONLY GOOD BEHAVIOR FOUND HERE

Conference (Washington State Dental Association), 2033 Sixth Ave., Suite 333, Seattle 98121, 1-206-448-1914, July 15-17, Seattle. Utah Dental Associat...

28KB Sizes 0 Downloads 48 Views

Conference (Washington State Dental Association), 2033 Sixth Ave., Suite 333, Seattle 98121, 1-206-448-1914, July 15-17, Seattle. Utah Dental Association, 1151 E. 3900 S, B160, Salt Lake City 84124, 1-801-261-5315, Feb. 4-6, 1999, Salt Lake City. Vermont State Dental

HEALTH MEDIA WATCH ONLY GOOD BEHAVIOR FOUND HERE

Dental treatment using con-

scious sedation, or CS, with physical restraint does not adversely affect the future dental behavior of young children, says a report in the March-April issue of Journal of Dentistry for Children. Israeli researchers compared the dental behavior of 24 young children previously treated at a private hospital under general anesthesia, or GA, with the behavior of 30 young children treated at a dental clinic under CS. At the beginning of the study, the children ranged in age from 36 to 72 months and were first-time patients who required extensive dental treatment. At a six-month recall examination, researchers separated parents from their children. Dentists asked parents to predict how they thought their children would behave at the recall examination. During the examination, dental assistants assessed the children’s responses to the dental setting by measuring their behavior and anxiety using the 836

Society, 100 Dorset St., Suite 18, South Burlington 05403, 1-802-864-0115, Sept. 25-26, Killington. Virginia Dental Association, P.O. Box 6906, Richmond 23230, 1-804-358-4927, Sept. 16-20, Williamsburg. West Virginia Dental Association, 300 Capitol St.,

Suite 1002, Charleston 25301, 1-304-344-5246, July 16-19, White Sulphur Springs. Wisconsin Dental Association, 111 E. Wisconsin Ave., Suite 1300, Milwaukee 53202, 1-414-276-4520, Sept. 26-28, Milwaukee.

Frankl Behavior Rating Scale. After the examination, the dental assistants asked the children about their dental fears and willingness to return to the dental clinic. Researchers found that 13 percent of GA patients’ parents and 14 percent of CS patients’ parents predicted their children would be anxious at the recall examination. They also found that while 17 percent of the GA patients and 20 percent of the CS patients reported being afraid to go to the dentist, 92 percent and 93 percent, respectively, exhibited positive behavior at the recall examination. (J Dent Child 1998;65:122-7)

Drug Resistance Surveillance between 1994 and 1997. The scientists analyzed data from cross-sectional ad hoc drugresistance surveys and surveillance program reports provided by the participating countries. These countries followed guidelines to ensure they used representative samples, took accurate treatment histories, followed standardized laboratory methods and used common definitions. A network of reference laboratories provided quality assurance. The number of patients studied in each country ranged from 59 to 14,344 with a median of 555. Scientists found that among patients being treated for TB for the first time, a median of 9.9 percent of the Mycobacterium tuberculosis strains tested were resistant to at least one drug. The prevalence of multidrug-resistant M. tuberculosis strains among first-time TB patients was 1.4 percent. Among patients with histories of TB treatment of one month or less, the prevalence of M. tuberculosis strains’ resistance to any one of the four drugs was 36 percent. Thirteen percent of the M. tuberculosis strains were resistant to two or more of the four first-line drugs. Drug-resistant TB evolves when TB treatment is incomplete or inappropriate, allowing some bacteria to survive and de-

DRUG-RESISTANT TB POSES GLOBAL THREAT

Strains of drug-resistant tuberculosis are surfacing worldwide and could threaten efforts to control the disease, according to a report in the June 4 issue of The New England Journal of Medicine. Scientists found strains of TB that are resistant to one or more of the four first-line drugs—isoniazid, streptomycin, rifampin and ethambutol—in all 35 countries that took part in the World Health Organization–International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis

Compiled by Anita M. Mark, senior editor, ADA News.

JADA, Vol. 129, July 1998 Copyright ©1998-2001 American Dental Association. All rights reserved.